CURIS, INC. Restricted Cash, Current
CURIS, INC. (CRIS) had Restricted Cash, Current of $544.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-14
- 2026-06-30: Restricted Cash, Current $544.00K.
- 2025-12-31: Restricted Cash, Current $0.00.
- 2020-12-31: Restricted Cash, Current $0.00.
- 2019-12-31: Restricted Cash, Current $153.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $544.00K 10-Q · filed 2026-08-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-16 |
| 2019-12-31 | $153.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |